Particle.news

Download on the App Store

New Reports Flag Alzheimer’s Detection Delays in Euskadi, Urge Action on Preventable Risks

Findings from the mapEA and Alma‑Care projects highlight referral bottlenecks, prompting calls for primary‑care training, clear pathways, blood biomarker screening, wider prevention.

Overview

  • Primary‑care time pressure and limited Alzheimer’s‑specific training are cited as barriers to early identification, according to new analyses shared for World Alzheimer’s Day.
  • In Euskadi, patients with suspected Alzheimer’s wait about six months for referral from primary care and roughly another six months to see a hospital specialist.
  • Only about half of primary‑care clinicians report knowing the referral protocol, with shortages of geriatricians and weak coordination further slowing diagnosis.
  • Experts call for targeted screening that includes emerging blood‑based biomarkers, coupled with upgraded training and streamlined referral pathways.
  • Specialists highlight that up to half of cases are linked to modifiable risks, noting estimates such as a 5% lower risk with higher education, small increases tied to depression and head injury, and smoking associated with up to a 50% higher risk.